Gary Holland to Infliximab
This is a "connection" page, showing publications Gary Holland has written about Infliximab.
Connection Strength
0.156
-
Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis. Ocul Immunol Inflamm. 2025 Aug; 33(6):948-956.
Score: 0.057
-
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality. Ophthalmology. 2023 12; 130(12):1258-1268.
Score: 0.051
-
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis Rheumatol. 2019 06; 71(6):864-877.
Score: 0.038
-
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001 Jun; 45(3):252-7.
Score: 0.011